PAXMAN receives second order from Teva in Mexico following successful market launch
PAXMAN announces that the company’s license partner Teva Pharmaceutical has ordered ten additional scalp cooling systems for Mexico after the successful market launch in November. Teva’s first order for 17 systems is currently being installed, with the first patient treatment at Centro Oncologico Internacional in Guadalajara last week.The market launch of the PAXMAN Scalp Cooling System in Mexico during a major exhibition event in Guadalajara in the middle of November was well received by leading cancer centres in the country. The demand is already substantial, and by quickly placing a